236 related articles for article (PubMed ID: 9392497)
1. Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Julien P; Vohl MC; Gaudet D; Gagné C; Lévesque G; Després JP; Cadelis F; Brun LD; Nadeau A; Ven Murthy MR
Diabetes; 1997 Dec; 46(12):2063-8. PubMed ID: 9392497
[TBL] [Abstract][Full Text] [Related]
2. Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study.
Ruel IL; Gaudet D; Perron P; Bergeron J; Julien P; Lamarche B;
Int J Obes Relat Metab Disord; 2003 May; 27(5):631-7. PubMed ID: 12704407
[TBL] [Abstract][Full Text] [Related]
3. Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.
Hölzl B; Kraft HG; Wiebusch H; Sandhofer A; Patsch J; Sandhofer F; Paulweber B
J Lipid Res; 2000 May; 41(5):734-41. PubMed ID: 10787434
[TBL] [Abstract][Full Text] [Related]
4. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
[TBL] [Abstract][Full Text] [Related]
5. Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency.
Garenc C; Couillard C; Laflamme N; Cadelis F; Gagné C; Couture P; Julien P; Bergeron J
Eur J Hum Genet; 2005 Oct; 13(10):1159-65. PubMed ID: 16015281
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Wilson DE; Emi M; Iverius PH; Hata A; Wu LL; Hillas E; Williams RR; Lalouel JM
J Clin Invest; 1990 Sep; 86(3):735-50. PubMed ID: 2394828
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase activity in heterozygotes for lipoprotein lipase gene mutations reveals a gender bias.
Murase T; Ebara T; Okubo M
Ann Clin Biochem; 2014 Mar; 51(Pt 2):294-7. PubMed ID: 24081181
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Syvänne M; Antikainen M; Ehnholm S; Tenkanen H; Lahdenperä S; Ehnholm C; Taskinen MR
J Lipid Res; 1996 Apr; 37(4):727-38. PubMed ID: 8732773
[TBL] [Abstract][Full Text] [Related]
9. Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Ando H; Nishimura Y; Nemoto T; Takamura T; Nagai Y; Kobayashi K
Endocr J; 2001 Feb; 48(1):113-8. PubMed ID: 11403097
[TBL] [Abstract][Full Text] [Related]
10. A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
Ikeda Y; Takagi A; Nakata Y; Sera Y; Hyoudou S; Hamamoto K; Nishi Y; Yamamoto A
Clin Chim Acta; 2002 Feb; 316(1-2):179-85. PubMed ID: 11750290
[TBL] [Abstract][Full Text] [Related]
11. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Nikkilä EA; Huttunen JK; Ehnholm C
Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
[TBL] [Abstract][Full Text] [Related]
12. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Elbein SC; Yeager C; Kwong LK; Lingam A; Inoue I; Lalouel JM; Wilson DE
J Clin Endocrinol Metab; 1994 Nov; 79(5):1450-6. PubMed ID: 7962342
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women.
Després JP; Ferland M; Moorjani S; Nadeau A; Tremblay A; Lupien PJ; Thériault G; Bouchard C
Arteriosclerosis; 1989; 9(4):485-92. PubMed ID: 2751477
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Minnich A; Kessling A; Roy M; Giry C; DeLangavant G; Lavigne J; Lussier-Cacan S; Davignon J
J Lipid Res; 1995 Jan; 36(1):117-24. PubMed ID: 7706936
[TBL] [Abstract][Full Text] [Related]
15. Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency.
Ginzinger DG; Clee SM; Dallongeville J; Lewis ME; Henderson HE; Bauje E; Rogers QR; Jensen DR; Eckel RH; Dyer R; Innis S; Jones B; Fruchart JC; Hayden MR
Eur J Clin Invest; 1999 Jan; 29(1):17-26. PubMed ID: 10092984
[TBL] [Abstract][Full Text] [Related]
16. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.
Coleman T; Seip RL; Gimble JM; Lee D; Maeda N; Semenkovich CF
J Biol Chem; 1995 May; 270(21):12518-25. PubMed ID: 7759497
[TBL] [Abstract][Full Text] [Related]
17. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.
Vohl MC; Lamarche B; Moorjani S; Prud'homme D; Nadeau A; Bouchard C; Lupien PJ; Després JP
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):714-20. PubMed ID: 7749885
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Kobayashi J; Takahashi K; Tashiro J; Shirai K; Saito Y; Yoshida S; Hashimoto H; Fukamachi I; Niihara K; Sasaki N
Arzneimittelforschung; 1994 Feb; 44(2):145-8. PubMed ID: 8147947
[TBL] [Abstract][Full Text] [Related]
20. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
